Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Resistant Gestational Trophoblastic Neoplasia Patients Treated with 5-Fluouracil plus Actinomycin D

  • Manopunya, Manatsawee (Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University) ;
  • Suprasert, Prapaporn (Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University)
  • Published : 2012.01.31
Download PDF
⟨ Previous Next ⟩

Abstract

A combination of 5-fluorouracil plus actinomycin D (5FU plus Act D) is the regimen that has been commonly administered to Chinese and Japanese gestational trophoblastic neoplasia patients as the first or second line of treatment with an excellent outcome. However, the efficacy of this regimen in a salvage setting was unclear. To evaluate the efficacy and safety of the 5 FU plus Act D regimen utilized in this condition, all GTN patients resistant to at least three previous chemotherapy regimens who received the 5 FU plus Act D regimen between August 2009 and January 2011 at Chiang Mai University Hospital were reviewed. There were five cases who met the criteria. Four of those patients were in FIGO stage III to IV with a WHO scoring of more than 12. The median number of cycles for each patient was two and only one case achieved remission while four of the cases were unresponsive. The toxicity was evaluated in 12 cycles. Common complications were uncomplicated myelosuppression and mucositis. In conclusion, this regimen revealed modest efficacy in a salvage setting with manageable toxicity.

Keywords

References

  1. Bolis G, Bonazzi C, Landoni F, et al (1998). EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT). Gynecol Oncol, 31, 439-44. https://doi.org/10.1016/S0090-8258(88)80029-5
  2. Bower M, Newlands ES, Holden L, et al (1997). EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. J Clin Oncol, 15, 2636-43. https://doi.org/10.1200/JCO.1997.15.7.2636
  3. Miller AV, Hoogstralen B, Staquet M, et al (1981). Reporting results of cancer treatment. Cancer, 47, 297-14.
  4. Matsui H, Suzuka K, Iitsuka Y, et al (2002). Salvage combination chemotherapy with 5-fluorouracil and actinomycin D for patients with refractory, high-risk gestational trophoblastic tumors. Cancer, 95, 1051-4. https://doi.org/10.1002/cncr.10790
  5. Lurain JR, Singh DK, Schink JC (2006). Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy. J Reprod Med, 51, 767-72.
  6. Wang S, An R, Han X, Zhu K, Xue Y (2006). Combination chemotherapy with 5-fluorouracil, methotrexate and etoposide for patients with high-risk gestational trophoblastic tumors: a report based on our 11-year clinical experiences. Gynecol Oncol, 103, 1105-8. https://doi.org/10.1016/j.ygyno.2006.06.031
  7. Zhao Y, Zhang W, Duan W (2009). Management of gestational trophoblastic neoplasia with 5-fluorouracil and actinomycin D in northern China. J Reprod Med, 54, 88-94.

Cited by

  1. Predictive Role of the Neutrophil Lymphocyte Ratio for Invasion with Gestational Trophoblastic Disease vol.15, pp.10, 2014, https://doi.org/10.7314/APJCP.2014.15.10.4203
  2. Multicenter Analysis of Gestational Trophoblastic Neoplasia in Turkey vol.15, pp.8, 2014, https://doi.org/10.7314/APJCP.2014.15.8.3625
  3. Management of Chemoresistant and Quiescent Gestational Trophoblastic Disease vol.3, pp.1, 2014, https://doi.org/10.1007/s13669-013-0071-6
  4. Tegafur Substitution for 5-Fu in Combination with Actinomycin D to Treat Gestational Trophoblastic Neoplasm vol.10, pp.11, 2015, https://doi.org/10.1371/journal.pone.0143531
  5. Quality of Life in Gestational Trophoblastic Neoplasia Patients after Treatment in Thailand vol.15, pp.24, 2015, https://doi.org/10.7314/APJCP.2014.15.24.10871
  6. Human Chorionic Gonadotropin (hCG) Regression Curve for Predicting Response to EMA/CO (Etoposide, Methotrexate, Actinomycin D, Cyclophosphamide and Vincristine) Regimen in Gestational Trophoblastic Neoplasia vol.16, pp.12, 2015, https://doi.org/10.7314/APJCP.2015.16.12.5037
  7. Outcomes of Non-Metastatic Gestational Trophoblastic Neoplasia: Twelve Year Experience from a Northern Thailand Tertiary Care Center vol.16, pp.14, 2015, https://doi.org/10.7314/APJCP.2015.16.14.5913
  8. FIGO stage IV gestational choriocarcinoma misdiagnosed as pulmonary tuberculosis: A�case report pp.1792-1082, 2015, https://doi.org/10.3892/ol.2015.3443
  9. Outcomes of Metastatic Gestational Trophoblastic Neoplasia: Fourteen Year Experience from a Northern Thailand Tertiary Care Center vol.17, pp.3, 2016, https://doi.org/10.7314/APJCP.2016.17.3.1357
  10. Uterine artery embolization combined with local infusion of methotrexate and 5- fluorouracil in treating ectopic pregnancy vol.97, pp.5, 2018, https://doi.org/10.1097/MD.0000000000009722